Product: Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6899-01
Reason for recall: cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure
Recall initiated: 20180424
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated